Patent Controversies in Psychedelics
What investors need to know about the intellectual property behind medicine’s next big growth area
patents
Psychedelic Business Spotlight – June 3
This week in psychedelic business news: Cybin moves towards clinical trials; Braxia releases data on treating depression with psilocybin; Clearmind files for a new patent; and much more!
Psychedelic Business Spotlight – May 27
This week in psychedelic business news: New patents; another Health Canada SAP Approval; and legal psilocybin rules for Oregon.
DMT Vape Pen Patent Illustrates a Big Problem in the Psychedelics Industry
Problematic patents have serious implications for the entire psychedelics industry.
Filament Health Patents Extraction Technique for Superior, Cheaper Natural Psilocybin
The Vancouver-based company says it has overcome the challenges of natural extraction with its new technology, which can produce superior psilocybin at a lower cost.
Mindset Pharma Files Patent for Quickest, Cheapest Method to Synthesize Psilocybin
“Based on our research, we think we’re able to get to psilocybin in fewer steps than any of the other published methods,” says the company’s CEO.
These 24 Psychedelic Patents Are Paving the Way for Medicine 2.0
Patents of psychedelic substances are paving the way for new research and treatment options for a variety of diseases.
End of content
End of content